Skip to main content
. 2017 Jun 7;22(10):1160–1168. doi: 10.1634/theoncologist.2017-0079

Table 1. Baseline characteristics (intent‐to‐treat population).

image

a

Paclitaxel, docetaxel, nab‐paclitaxel, or taxane (not otherwise specified).

b

Epirubicin, doxorubicin, mitoxantrone, or anthracycline (not otherwise specified).

Abbreviation: ECOG, Eastern Cooperative Oncology Group.